# US 2026/0085099 A1 · Isolation of Osteopontin and Glycomacropeptide from Whey

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0085099 A1
- Document ID: US20260085099A1
- Status: Published application
- Kind: A1
- Application number: 19/111,893
- Filed: 2023-09-15
- Published: 2026-03-26
- Earliest claimed: 2022-09-16
- Assignees: Univerza v Ljubljani; Arhel Projektiranje In Inzeniring D.O.O.
- Applicants: Univerza V Ljubljani; ARHEL Projektiranje in Inzeniring D.O.O.
- Inventors: Jernej Oberckal; Bojana Bogovic Matijasic; Maja Zupancic Justin
- Web page: https://patentgrep.com/patent/US20260085099A1

## CPC

- C07K 14/4702: {Regulators; Modulating activity}
- C07K 14/52: Cytokines; Lymphokines; Interferons
- C07K 14/4732: {Casein (in foodstuffs A23J)}
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention generally relates to the dairy industry, and specifically to the isolation and purification of osteopontin and glycomacropeptide, wherein is provided with a process for the isolation of osteopontin (OPN) or glycomacropeptide (GMP) from whey or a whey derived liquid comprising the steps of absorption onto a monolithic chromatography column, an optional washing of the column and subsequent elution of said OPN or GMP using a change in salt concentration and/or pH.

## Claims

### Claim 1

A process for the isolation of osteopontin (OPN) or glycomacropeptide (GMP) from whey or a whey-derived liquid comprising the steps of absorption onto a monolithic chromatography column, an optional washing of the column and subsequent elution of said OPN or GMP using a change in salt concentration and/or pH.

### Claim 2 (depends on 1)

The process according to claim 1, wherein the monolithic column is loaded with whey or whey-derived liquid with such flow rate and in such quantity that OPN displaces more weakly binding substances from the column.

### Claim 3 (depends on 1)

The process according to claim 1, wherein the monolithic column is loaded with whey or whey-derived liquid with a flow rate in the range from about 0.1 mL per mL of column volume per minute to about 20 mL per mL of column volume per minute, or in the range from about 0.1 mL per mL of column volume per minute to about 5 mL per mL of column volume per minute.

### Claim 4 (depends on 1)

The process according to claim 1, wherein said elution comprises the use of an eluent having a higher ionic strength than said whey or whey derived liquid loaded onto said monolithic chromatography column.

### Claim 5 (depends on 1)

The process according to claim 1, wherein said elution comprises the use of an eluent having a pH lower than the pH of said whey or whey-derived liquid loaded onto said monolithic chromatography column.

### Claim 6 (depends on 1)

The process according to claim 1, wherein said elution is performed by the use of a change in salt concentration and a change in pH.

### Claim 7 (depends on 6)

The process according to claim 6, wherein the elution is performed by a step change of the salt concentration and a gradient change of the pH.

### Claim 8 (depends on 6)

The process according to claim 6, wherein the elution is performed by a step change of the pH and a gradient change of the salt concentration.

### Claim 9 (depends on 1)

The process according to claim 1, wherein OPN and GMP are eluted separately such that separate fractions are obtained where one fraction comprises the majority of said OPN and a second fraction comprises the majority of said GMP.

### Claim 10 (depends on 1)

The process according to claim 1, wherein said absorption onto a monolithic chromatography column is a high-performance liquid chromatography (HPLC), such as anion-exchange HPLC.

### Claim 11 (depends on 1)

The process according to claim 1, wherein said whey or whey derived liquid is filtered prior to said absorption, such as by microfiltration.

### Claim 12 (depends on 1)

The process according to of claim 1, wherein said monolithic chromatography column following the elution is regenerated by a solution having a concentration of sodium chloride in the range from about 0.8M to about 2.0M, and optionally pH in the range from about 2.5 to about 3.5.

### Claim 13 (depends on 1)

A method for preparing OPN or GMP comprising the process as defined in claim 1.

### Claim 14 (depends on 13)

The method according to claim 13, further comprising a desalination step.

### Claim 15 (depends on 13)

The method according to claim 13, comprising a further chromatography step.

### Claim 16 (depends on 13)

The method according to claim 13, further comprising a lyophilisation, spray drying or other form of drying to obtain a solid OPN or GMP product.
